Habitual abortion – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:37:26 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Habitual abortion – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Hydroxychloroquine for Women with Recurrent Pregnancy Loss https://clinicaltrials.eu/trial/study-on-hydroxychloroquine-for-women-with-recurrent-pregnancy-loss/ Wed, 29 Apr 2026 15:01:27 +0000 https://clinicaltrials.eu/trial/study-on-hydroxychloroquine-for-women-with-recurrent-pregnancy-loss/ This clinical trial is focused on studying Recurrent Pregnancy Loss, a condition where a woman experiences multiple pregnancy losses before the 22nd week of gestation. The trial is testing the effectiveness of a treatment using Hydroxychloroquine, a medication that is commonly used for other conditions but is being explored here for its potential benefits in improving pregnancy outcomes.

The purpose of the study is to compare the live birth rates between women who receive Hydroxychloroquine and those who receive a placebo. Participants in the study will be randomly assigned to one of these two groups. The study will follow each participant through their pregnancy journey, concluding either after a pregnancy loss or six months after a live birth. If a participant becomes pregnant less than two months after starting the medication or does not achieve pregnancy within a year, they will be replaced by a new participant to ensure the study’s goals are met.

The trial aims to include and follow up with 186 women to gather comprehensive data on the effectiveness of Hydroxychloroquine in treating Recurrent Pregnancy Loss. This research could provide valuable insights into new treatment options for women experiencing this challenging condition.

]]> Study on Prednisolone for Women with Unexplained Recurrent Miscarriages https://clinicaltrials.eu/trial/study-on-prednisolone-for-women-with-unexplained-recurrent-miscarriages/ Wed, 29 Apr 2026 14:26:38 +0000 https://clinicaltrials.eu/trial/study-on-prednisolone-for-women-with-unexplained-recurrent-miscarriages/ The PREMI trial is focused on studying the condition known as unexplained recurrent miscarriages, which affects some women during early pregnancy. This condition is characterized by experiencing multiple miscarriages without a known cause. The trial aims to explore the effects of a medication called prednisolone, which is a type of steroid, in comparison to a placebo. Prednisolone is taken in tablet form and is being investigated to see if it can help improve the chances of a successful pregnancy and live birth for women who have experienced this condition.

The purpose of the study is to assess whether taking prednisolone during early pregnancy can increase the live birth rate among women with unexplained recurrent miscarriages. Participants in the study will be randomly assigned to receive either prednisolone or a placebo. The study will follow the participants throughout their pregnancy to monitor the outcomes and gather data on the effectiveness of the treatment.

This trial is designed to provide valuable insights into whether prednisolone can be a beneficial treatment option for women facing unexplained recurrent miscarriages. The study will continue until all participants have completed their final visits, and all necessary data has been collected. The results of this research could potentially lead to new treatment approaches for improving pregnancy outcomes in affected women.

]]>